Genomictree Inc. (KOSDAQ:228760)
27,700
0.00 (0.00%)
At close: Dec 5, 2025
Genomictree Market Cap
Genomictree has a market cap or net worth of 665.42 billion as of December 5, 2025. Its market cap has increased by 69.70% in one year.
Market Cap
665.42B
Enterprise Value
582.59B
Revenue
3.76B
Ranking
n/a
PE Ratio
n/a
Stock Price
27,700.00
Market Cap Chart
Since April 5, 2017, Genomictree's market cap has increased from 59.00B to 665.42B, an increase of 1,027.85%. That is a compound annual growth rate of 32.22%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.96T |
| Celltrion | 40.11T |
| ALTEOGEN | 24.41T |
| ABL Bio | 10.51T |
| SK Biopharmaceuticals | 10.49T |
| Yuhan | 8,755.13B |
| LigaChem Biosciences | 6,753.15B |
| Peptron | 6,540.52B |